Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Neurol ; 70(2): 327-40, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21823158

ABSTRACT

OBJECTIVE: To characterize cognitive and behavioral features, physical findings, and brain atrophy patterns in pathology-proven corticobasal degeneration (CBD) and corticobasal syndrome (CBS) with known histopathology. METHODS: We reviewed clinical and magnetic resonance imaging data in all patients evaluated at our center with either an autopsy diagnosis of CBD (n = 18) or clinical CBS at first presentation with known histopathology (n = 40). Atrophy patterns were compared using voxel-based morphometry. RESULTS: CBD was associated with 4 clinical syndromes: progressive nonfluent aphasia (n = 5), behavioral variant frontotemporal dementia (n = 5), executive-motor (n = 7), and posterior cortical atrophy (n = 1). Behavioral or cognitive problems were the initial symptoms in 15 of 18 patients; less than half exhibited early motor findings. Compared to controls, CBD patients showed atrophy in dorsal prefrontal and perirolandic cortex, striatum, and brainstem (p < 0.001 uncorrected). The most common pathologic substrates for clinical CBS were CBD (35%), Alzheimer disease (AD, 23%), progressive supranuclear palsy (13%), and frontotemporal lobar degeneration (FTLD) with TDP inclusions (13%). CBS was associated with perirolandic atrophy irrespective of underlying pathology. In CBS due to FTLD (tau or TDP), atrophy extended into prefrontal cortex, striatum, and brainstem, whereas in CBS due to AD, atrophy extended into temporoparietal cortex and precuneus (p < 0.001 uncorrected). INTERPRETATION: Frontal lobe involvement is characteristic of CBD, and in many patients frontal, not parietal or basal ganglia, symptoms dominate early stage disease. CBS is driven by medial perirolandic dysfunction, but this anatomy is not specific to a single underlying histopathology. Antemortem prediction of CBD will remain challenging until clinical features of CBD are redefined, and sensitive, specific biomarkers are identified.


Subject(s)
Basal Ganglia/pathology , Basal Ganglia/physiopathology , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/physiopathology , Aged , Aged, 80 and over , Autopsy , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurodegenerative Diseases/diagnosis , Neuropsychological Tests , Syndrome
2.
J Geriatr Psychiatry Neurol ; 23(4): 260-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20938042

ABSTRACT

The purpose of this review is to provide a comprehensive update on the genetic causes of frontotemporal lobar degeneration (FTLD). Approximately 40% to 50% of patients diagnosed with FTLD have a family history of a ''related disorder,'' whereas 10% to 40% have an autosomal dominant family history for the disease. At this time, mutations occurring in 2 independent genes located on the same chromosome (MAPT and GRN) have been shown to cause the majority of cases of autosomal dominant FTLD. Specific genetic, molecular, pathological, and phenotypic variations associated with each of these gene mutations are discussed, as well as markers that may help differentiate the 2. In addition, 3 relatively rare, additional genes known to cause familial FTLD are examined in brief. Lastly, genetic counseling issues which may be important to the community clinician are discussed.


Subject(s)
Adenosine Triphosphatases/genetics , Brain/pathology , Cell Cycle Proteins/genetics , DNA-Binding Proteins/genetics , Endosomal Sorting Complexes Required for Transport/genetics , Frontotemporal Lobar Degeneration/genetics , Intercellular Signaling Peptides and Proteins/genetics , Nerve Tissue Proteins/genetics , tau Proteins/genetics , Animals , Family , Frontotemporal Lobar Degeneration/pathology , Frontotemporal Lobar Degeneration/psychology , Genetic Counseling , Genetic Predisposition to Disease , Genetic Variation , Genotype , Humans , Mutation , Phenotype , Progranulins , Tomography, X-Ray Computed , Valosin Containing Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...